A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2006
12/20/2006	CN1290527C External remedy for treating sore, bouton, nail-like boil, and carbuncle
12/20/2006	CN1290525C A blood-sugar lowering botanical extract and its use
12/20/2006	CN1290523C Chinese medicine tighten ointment for treating vagina laxation
12/20/2006	CN1290520C Method for preparing hepatitis treating medicine and the product produced thereby
12/20/2006	CN1290519C Effective part extract of Chinese medicine drynaria rhizome and its extracting method
12/20/2006	CN1290517C Preparation method of combination of propolis
12/20/2006	CN1290516C Compound medicine compatibility method of ion pair agent and vanadium compound and the application thereof
12/20/2006	CN1290513C Compound capsule of amino acid and chitosan
12/20/2006	CN1290512C Pharmaceutical composition containing ginseng polysacchride and astragalus polysaccharide, its preparation and application
12/20/2006	CN1290511C Doxorubicin liposome hydrochloride preparation and its preparing method
12/20/2006	CN1290510C Pharmaceutical composition containing gen-seng total saponin and astragalus root total saponin, its preparing process and application
12/20/2006	CN1290508C Traditional Chinese medicinal preparation for treating chronic bronchitis, its preparation method and application
12/20/2006	CN1290507C Steroid hormone products and preparing method thereof
12/20/2006	CN1290506C Medicinal composition
12/20/2006	CN1290505C PH sensitive controllable nanometer particle carried with 5-Fu and its preparation method
12/20/2006	CN1290502C Compositions for treatment of common cold
12/20/2006	CN1290496C Clenbuterol hydrochloride plaster
12/20/2006	CN1290495C Lipid microspherical asarol preparation and its preparation process
12/20/2006	CN1290494C Externally applied long-acting analgesic
12/20/2006	CN1290493C Local therapy for skin virus infection
12/20/2006	CN1290492C Beta-elemene aerosol and its preparing method
12/20/2006	CN1290491C Medicine for treating acute ischemic cerebral apoplexy and its preparing method
12/20/2006	CN1290490C Preparation process of soluble licorice powder
12/20/2006	CN1290489C Toad extract liposome preparation for injection and its preparing method
12/20/2006	CN1290488C Application of micro bubble reagent for blood vessel embolism operation induced by ultrasonic and fat-reducing beautifying operation
12/20/2006	CN1290441C Rye-red yeast vinegar soft capsule and its preparing method
12/19/2006	US7151961 Treatment of movement disorders by brain stimulation
12/19/2006	US7151191 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
12/19/2006	US7151183 Processes for preparing amorphous atorvastatin hemi-calcium
12/19/2006	US7151090 Methods for enhancing graft survival by modulating heme oxygenase activity
12/19/2006	US7151077 Polymersome compositions and associated methods of use
12/19/2006	US7150883 Liposome suspension forms spontaneously upon adding a diacylglycerol-PEG lipid to an aqueous solution when the lipid has appropriate packing parameters and the adding occurs above the melting temperature of the lipid
12/19/2006	US7150882 Enhanced circulation effector composition and method
12/19/2006	US7150881 Patches; sustained release drug delivery
12/19/2006	US7150880 Drink for athletes; creatine plays a pivotal role in the regulation and homeostasis of skeletal muscle energy metabolism
12/19/2006	US7150869 Gene therapy; cytokine complex; anticancer agent
12/19/2006	US7150867 Radionuclide-coated particulate material
12/19/2006	US7150766 Method of particle formation
12/19/2006	US7150741 Programmable dose control module
12/19/2006	US7150623 Tablets containing heat sensitive materials and method for forming thereof
12/19/2006	CA2364610C Pharmaceutical solubilized in aerosol propellant
12/19/2006	CA2358062C Controlled release galantamine composition
12/19/2006	CA2356020C Cannabinoid patch and method for cannabis transdermal delivery
12/19/2006	CA2320087C Treatment of chronic inflammatory disorders of the gastrointestinal tract
12/19/2006	CA2301685C Sustained release drug delivery devices
12/19/2006	CA2301577C Glucose-containing preparation
12/19/2006	CA2284929C Implantable delivery device with self adjustable exit port
12/19/2006	CA2267973C Hydrophilic microparticles and methods to prepare same
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2234957C Insoluble drug delivery
12/19/2006	CA2232880C Semi-fluorinated alkanes and their use
12/19/2006	CA2212537C Therapeutic inhibitor of vascular smooth muscle cells
12/19/2006	CA2200966C Pharmaceutical compositions
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2190778C Transmucosal delivery system
12/19/2006	CA2188297C Lactone stable formulation of camptothecin or 7-ethyl camptothecin
12/19/2006	CA2162208C Percutaneous absorption preparation
12/19/2006	CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/14/2006	WO2006133349A2 Orally disintegrable sleep aid formulations
12/14/2006	WO2006133194A2 Methods for treating viral infection with oral or injectible drug solution
12/14/2006	WO2006133131A1 Compositions for drug delivery
12/14/2006	WO2006133120A1 Rapidly dissolving gelatin compositions and products made therefrom
12/14/2006	WO2006133047A1 Attachment of a handle to a solid oral dosage form
12/14/2006	WO2006133046A2 Nanoparticulate imatinib mesylate formulations
12/14/2006	WO2006132879A2 Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
12/14/2006	WO2006132870A1 Ophthalmic solution with a flavoring agent
12/14/2006	WO2006132868A1 Ophthalmic solution with a flavoring agent as a dosing indicator and method for indicating dosage of an ophthalmic solution
12/14/2006	WO2006132867A1 Topical oligopeptide delivery system
12/14/2006	WO2006132752A1 Nanoparticulate and controlled release compositions comprising vitamin k2
12/14/2006	WO2006132440A1 Solid preparation
12/14/2006	WO2006132403A1 Mri contrast medium containing liposomes
12/14/2006	WO2006132388A1 Bone marrow-directing drug delivery materials and their applications
12/14/2006	WO2006132363A1 Stabilizer for protein preparation comprising meglumine and use thereof
12/14/2006	WO2006132360A1 Sugar-coated tablet
12/14/2006	WO2006132352A1 Pharmaceutical composition containing sc(fv)2
12/14/2006	WO2006132342A1 Eye drop containing roflumilast
12/14/2006	WO2006132307A1 Stabilized milnacipran formulation
12/14/2006	WO2006132217A1 Crystal of salt of benzimidazole compound
12/14/2006	WO2006131931A2 Patch for transdermal drug delivery
12/14/2006	WO2006131806A2 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
12/14/2006	WO2006131790A2 Oral ribavirin pharmaceutical composition
12/14/2006	WO2006131737A2 Method and composition for treating inflammatory disorders
12/14/2006	WO2006131730A1 Glp-1 analogue formulations
12/14/2006	WO2006131721A2 Topical ungual formulations
12/14/2006	WO2006131591A2 An entacapone-containing oral dosage form
12/14/2006	WO2006131570A2 Method for producing an active substance-containing composite material
12/14/2006	WO2006131566A2 Oral ribavirin pharmaceutical compositions
12/14/2006	WO2006131481A1 Production of solid solutions based on poorly-soluble active substances by a short-term heating and rapid drying
12/14/2006	WO2006131401A2 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
12/14/2006	WO2006131394A1 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
12/14/2006	WO2006131393A1 Immediate-release and high-drug-load pharmaceutical formulations of non-micronised (4-chlorophenyl)[4-(4-pyridylmethyl)phthalazin-1-yl] and salts thereof
12/14/2006	WO2006131392A1 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/14/2006	WO2006131262A1 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations
12/14/2006	WO2006131054A1 Chinese pharmaceutical ophthalmological formulations in forms of solutions, ointments and pills for antiaging recovery
12/14/2006	WO2006130943A1 Respirable dried powder formulation comprising drug loaded nanoparticles
12/14/2006	WO2006130904A1 Dried formulations of nanoparticle-coated capsules
12/14/2006	WO2006121979A3 Modified-release pharmaceutical compositions
12/14/2006	WO2006116596A3 Micronized tanaproget and compostions containing same
12/14/2006	WO2006116514A3 Micronized tanaproget, compositions, and methods of preparing the same
12/14/2006	WO2006113631A3 Bioenhanced compositions

1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 2991